CONMED Corporation Declares Quarterly Cash Dividend

CONMED Corporation (NYSE: CNMD) made an announcement in a recent 8-K filing on December 9, 2024. The Board of Directors at CONMED declared a quarterly cash dividend of $0.20 per share. This dividend is set to be payable on January 3, 2025, to all shareholders of record as of December 20, 2024.

The declaration comes as part of the company’s commitment to returning value to its shareholders. The quarterly cash dividend reaffirms CONMED’s focus on enhancing shareholder returns while maintaining a sustainable financial profile.

Investors and shareholders can anticipate the upcoming dividend payment as scheduled, providing them with a steady income stream from their investment in CONMED Corporation. The company continues to prioritize shareholder value as it moves forward with its strategic initiatives.

For further information on the dividend payment and other financial updates, interested parties can refer to the details provided in the 8-K filing on the Securities and Exchange Commission’s website.

This news reflects CONMED’s ongoing efforts to create value for its investors through consistent dividend payments, reinforcing its position as a reliable investment opportunity in the market.

This article was generated by an automated content engine and was reviewed by a human editor prior to publication. For additional information, read CONMED’s 8K filing here.

CONMED Company Profile

CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. The company offers orthopedic surgery products, including BioBrace, TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors, which provide clinical solutions to orthopedic surgeons for the augmentation and repair of soft tissue injuries, as well as provides supporting products that enable surgeons to perform minimally invasive sports medicine surgeries.